Phase 1/2a study of Mogamulizumab, an anti-CCR4 monoclonal antibody, in patients with HTLV-1-associated myelopathy (HAM/TSP)

著录项

• 来源
  《Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology》 |2017年第2017期|共2页
• 作者

  Y. Yamano; T. Sato; A. Coler-Reilly; N. Yagishita; N. Araya; E. Inoue; R. Furuta; T. Watanabe; K. Uchimaru; M. Matsuoka; N. Matsumoto; Y. Hasegawa;

  展开▼
• 作者单位

  St. Marianna University Department of Rare Diseases Research kawasaki;

  St. Marianna University Department of Rare Diseases Research kawasaki;

  St. Marianna University Department of Rare Diseases Research kawasaki;

  St. Marianna University Department of Rare Diseases Research kawasaki;

  St. Marianna University Department of Rare Diseases Research kawasaki;

  National Center for Child Health and Development Center for Clinical Research and Development;

  Kyoto University Laboratory of Virus Control;

  St. Marianna University Deaprtment of Advanced Medical Innovation;

  The University of Tokyo Department of Computational Biology and Medical Sciences;

  Kyoto University Laboratory of Virus Control;

  St. Marianna University Department of Pharmacology;

  St. Marianna University Department of Neurology;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 神经病学;
• 关键词